To The Moon

$TONGCHENGTRAVEL(00780)$ 同程旅行（0780.HK）作為中國領先的旅遊預訂平台，近期因京東（09618.HK）進軍外賣與旅遊相關業務，引發市場對其競爭加劇的擔憂，股價出現短期下跌。然而，這種調整可能為投資者提供了入場機會。以下分析同程旅行的投資價值、競爭格局及當前股價的吸引力。同程旅行的基本面優勢同程旅行2025年第一季財報顯示，收入達38.7億元人民幣，同比增長13%，經調整淨利潤5.6億元，符合市場預期。毛利率從65%提升至68.8%，顯示其盈利能力穩健。公司背靠騰訊與攜程的流量與資源，深耕下沉市場，平台滲透率持續提升。旗下HopeGoo平台與AlipayHK合作，新增火車票預訂功能，進一步拓展香港及國際市場，顯示其業務多元化策略的成效。券商如高盛、華泰證券等維持「買入」評級，目標價介乎25.5至28.7港元，反映市場對其長期增長潛力的信心。京東競爭的影響近期，京東通過Joybuy及ochama拓展歐洲零售業務，並試水旅遊相關服務，與同程旅行形成潛在競爭。X平台上有分析指出，京東的電商與物流優勢可能挑戰同程的市場份額，導致同程股價一度下跌近14%，最低觸及18.28港元。然而，京東的外賣與旅遊業務仍處早期階段，與同程的專業旅遊平台相比，短期內難以撼動其核心競爭力。此外，同程的微信小程序與低線城市布局形成壁壘，非電商平台短期難以複製。入場時機分析同程旅行當前股價較52週高點回落約20%，估值回歸至2024年預測市盈率19倍，處於歷史低位。地緣政治風險（如中東衝突推高油價）可能影響旅遊需求，但中國國內旅遊市場保持穩定增長，特別是多元化旅遊體驗需求上升，為同程提供了增長空間。技術面看，股價接近20天均線支撐位，若能企穩，可能迎來反彈。投資建議同程旅行短期股

Sometimes, those higher-risk/gray area stocks will give us massive gains.Other times, they’ll fall on their face.We’ve seen both at $Hims & Hers Health Inc.(HIMS)$ this year alone.For better or worse, this has been the most controversial stock I’ve covered on Asymmetric Investing, as everyone seems to have an opinion about the company and its stock.Hims & Hers is the best stock ever!Hims & Hers is going to ZERO!Lawsuits are coming!OMG, the Europe acquisition changes everything!None of these takes is 100% right. None of them is 100% wrong. There are opportunities and risks.When you’re trying to disrupt healthcare, it’s going to be…messy.We saw that firsthand this week when $Novo-Nordisk A/S(NVO)$

$TSLA 20250627 380.0 CALL$ Taking profit to be on the safe side. No one know when tesla would suddenly to the moon. 😂

$Tesla Motors(TSLA)$ Robotaxi正式发布效果不错，加仓。但依然没有到目标仓位，等待将来任何回调时继续买入

$Pony AI Inc(PONY)$ Have been waiting for prices to dip given the current geopolitical situation. Decided to DCA today as Feds seem to be a lot more dovish than anticipated.

$Nike(NKE)$ is slated to release its fiscal Q4 2025 financial results on Thursday, 26 June 2025, after the market closes. Revenue: Analysts widely expect a significant year-over-year decline in revenue. The Zacks Consensus Estimate is pegged at approximately $10.67 billion to $10.72 billion, representing a 15% to 15.4% drop from the prior year. This aligns with Nike's own guidance of a mid-teens revenue decline for the quarter. Earnings Per Share (EPS): A substantial decline in EPS is also anticipated. The consensus estimate is around $0.11 to $0.12 per share, indicating a sharp decrease of around 89.1% from the $1.01 reported in Q4 2024. Analyst Expectations and Key Metrics Gross Margin: Gross margin is projected to decline significantly, with est

$RGTI 20250703 10.0 PUT$ Selling new puts on this volatile counter. So far price had came down a fair bit but hovers above $10 providing the temporary support. Premium is attractive for a contract that's less than 2 weeks till expiry. 

$CELH 20250703 41.0 PUT$ Selling new put to replace the one that expired last week. CELH had been really bullish and have sustained momentum so far. Selling shorter term puts to capture premium closer to strike, while keeping trade size small for risk control.

$TSLA 20250703 400.0 CALL$ Opsss. Greedy and hoping to gain some premium but i hope i wont regret this. Seems like very strong trend

$TSLA 20250627 385.0 CALL$ Sold tsla covered call on this huge rally $360 is a strong resistance I believe it will consolidate ard this range

$AMD 20250815 100.0 PUT$ Recently, Melius Research upgraded AMD to “Buy” and raised its target to $175, citing gains in AI accelerators like MI350 and Helios systems. This bullish sentiment boosts implied volatility and option premiums. Hence shorting a far priced put is a bullish yet safe idea. 

$OSCR 20250703 19.0 PUT$ Selling puts to collect premiums while waiting for share price to retrace from resistance/ huge volume shelf at ~21. Gap might be filled at ~18 to 19, happy to scoop the shares up to start a small position given the huge accumulation by the whales recently.

$LABU 20250627 43.5 PUT$ 今日回升，正所謂，早賣早享受，遲買賺少幾舊。都已經好耐無跌到去45之下。因為我都覺得45係唔安全，所以我再賣低一點，賣43.5[贱笑]  。期權金有0.15。亦屬高水平，低風險之作[胜利]  

$MSTR 20250711 400.0 CALL$ MSTR: collect 1.05% premium for this sold call with strike at $400. Contract expires in 3 weeks on 11th July. BTC is testing $100k support but I think this might rebound slightly higher as it's ranging between this support to high of $112k. Short term wise, I think MSTR is weaker than BTC itself with its valuation a concern to me. Might be a contrarian view, but I will stay true with my conviction until I see new information that will change my mind. 

$ProShares UltraPro Short QQQ(SQQQ)$ 千萬不要沽美股，千萬不要沽美股，我每天也是和自己這樣說，不過還是忍不住

$BABA-W(09988)$ 今日又以113.1賣出巴巴正股，如果以帳面計呢一注我係要蝕錢，因為之前賣put,115接返黎。又賣過兩次call,，收反過期權金，計落又差不多，就黎半年大結算，收反d現金，保住整體盈利就算了[胜利]  [胜利]  

$MET.HK 20250627 122.50 PUT$ 今日都算做左好多單生意，雖然大市上升賣遠價put期權金就唔會好，不過都係唔好咁勇啦，大升高追好易中伏，猶由環境不明朗，雖升3690今日升，但都係賣遠一點會比較好[胜利]  

$GOOGL 20260918 80.0 PUT$ Collect premium on a down day since Google is the only one weak today . Looking for a quick in and out . 

$PLTR 20250703 145.0 CALL$ PLTR: collect 1.9% premium on this sold call with strike at $145.Contract expires in 2 weeks on 3rd July. Seeing a potential topping and consolidation on PLTR as the recent bullish momentum is slowing down. Looking for possible short term correction if possible. Set aggressive $145 strike on resistance level to capture more premium while also aware of increased risk of assignment.